# INVO Fertility, Inc.: filings

IVF · Nasdaq · CIK 1417926 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ivf.md) · [Financials](/companies/ivf/financials.md) · [Filings](/companies/ivf/filings.md) · [Insiders](/companies/ivf/insiders.md)

## Reports and events: 284 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 167, 4 91, 10-Q 41, 5 27, CORRESP 22, 3 18, UPLOAD 16, 10-K 14, 424B3 14, S-1/A 14, EFFECT 13, 10-K/A 11, 8-K/A 11, S-1 11, DEF 14A 10, NT 10-K 10, NT 10-Q 9, S-8 8, 144 7, DEFA14A 7, PRE 14A 7, D 6, SC 13G/A 6, SCHEDULE 13G 6, SC 13G 5, SCHEDULE 13G/A 5, 424B4 4, SC 13D 4, 424B5 3, D/A 2, S-3 2, 10-Q/A 1, 424B7 1, 8-A12B 1, 8-A12G 1, CERT 1, DEFR14A 1, FWP 1, POS AM 1, POS EX 1, RW 1, S-3/A 1, S-4 1, SC TO-C 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-28 | 12:30 ET | [8-K](/filings/0001493152-26-040504.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-040504 |
| 2026-08-17 | 12:35 ET | [8-K](/filings/0001493152-26-038648.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-038648 |
| 2026-08-14 | 21:27 ET | [10-Q](/filings/0001493152-26-038528.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038528 |
| 2026-07-24 | 21:20 ET | [S-1](/filings/0001493152-26-034621.md) | Registration statement | 0001493152-26-034621 |
| 2026-07-24 | 21:14 ET | [8-K](/filings/0001493152-26-034616.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-034616 |
| 2026-06-25 | 20:52 ET | [8-K](/filings/0001493152-26-030147.md) | 1.01 Entry into a material agreement; 8.01 Other events | 0001493152-26-030147 |
| 2026-06-23 | 20:05 ET | [DEF 14A](/filings/0001493152-26-029785.md) | Proxy statement, period 2026-06-23 | 0001493152-26-029785 |
| 2026-06-22 | 13:05 ET | [8-K](/filings/0001493152-26-029517.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-029517 |
| 2026-06-22 | 13:00 ET | [10-Q](/filings/0001493152-26-029514.md) | Quarterly report, period 2026-03-31 | 0001493152-26-029514 |
| 2026-06-16 | 21:00 ET | [8-K](/filings/0001493152-26-028910.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028910 |
| 2026-06-12 | 20:29 ET | [10-K/A](/filings/0001493152-26-028454.md) | Annual report, amended, period 2025-12-31 | 0001493152-26-028454 |
| 2026-06-02 | 12:40 ET | [8-K](/filings/0001493152-26-026777.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-026777 |
| 2026-06-02 | 12:36 ET | [10-K](/filings/0001493152-26-026775.md) | Annual report, period 2025-12-31 | 0001493152-26-026775 |
| 2026-06-02 | 12:30 ET | [8-K](/filings/0001493152-26-026772.md) | 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001493152-26-026772 |
| 2026-04-29 | 20:15 ET | [8-K](/filings/0001493152-26-019593.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-019593 |
| 2026-03-31 | 20:30 ET | [8-K](/filings/0001493152-26-014227.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-014227 |
| 2026-02-24 | 14:00 ET | [8-K](/filings/0001493152-26-007830.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-007830 |
| 2026-02-02 | 21:47 ET | [S-1](/filings/0001493152-26-004766.md) | Registration statement | 0001493152-26-004766 |
| 2026-01-30 | 21:05 ET | [8-K](/filings/0001493152-26-004484.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-004484 |
| 2026-01-26 | 22:03 ET | [8-K](/filings/0001493152-26-003628.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-003628 |
| 2026-01-06 | 21:05 ET | [8-K](/filings/0001493152-26-000592.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-000592 |
| 2025-12-18 | 21:05 ET | [DEF 14A](/filings/0001493152-25-028349.md) | Proxy statement, period 2025-12-18 | 0001493152-25-028349 |
| 2025-12-17 | 21:42 ET | [S-1](/filings/0001493152-25-028163.md) | Registration statement | 0001493152-25-028163 |
| 2025-12-17 | 14:05 ET | [8-K](/filings/0001493152-25-028070.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-028070 |
| 2025-12-05 | 22:01 ET | [8-K](/filings/0001493152-25-026427.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-026427 |
| 2025-12-03 | 21:46 ET | [8-K](/filings/0001493152-25-025977.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-025977 |
| 2025-11-17 | 13:43 ET | [8-K](/filings/0001493152-25-023779.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-023779 |
| 2025-11-17 | 12:00 ET | [10-Q](/filings/0001493152-25-023751.md) | Quarterly report, period 2025-09-30 | 0001493152-25-023751 |
| 2025-10-22 | 20:05 ET | [8-K](/filings/0001493152-25-018911.md) | 3.02 Unregistered sale of equity | 0001493152-25-018911 |
| 2025-10-14 | 20:45 ET | [S-1](/filings/0001493152-25-018032.md) | Registration statement | 0001493152-25-018032 |
| 2025-10-10 | 20:05 ET | [8-K](/filings/0001493152-25-017752.md) | 3.02 Unregistered sale of equity | 0001493152-25-017752 |
| 2025-10-03 | 20:05 ET | [8-K](/filings/0001493152-25-016850.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-016850 |
| 2025-09-29 | 21:31 ET | [8-K](/filings/0001493152-25-016076.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-016076 |
| 2025-09-26 | 21:30 ET | [8-K](/filings/0001493152-25-015821.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-015821 |
| 2025-09-12 | 20:12 ET | [8-K](/filings/0001641172-25-027201.md) | 3.02 Unregistered sale of equity | 0001641172-25-027201 |
| 2025-09-05 | 21:29 ET | [8-K](/filings/0001641172-25-026757.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-026757 |
| 2025-08-22 | 21:24 ET | [8-K](/filings/0001641172-25-025270.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001641172-25-025270 |
| 2025-08-15 | 18:03 ET | [8-K](/filings/0001641172-25-024338.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-024338 |
| 2025-08-14 | 21:28 ET | [10-Q](/filings/0001641172-25-024212.md) | Quarterly report, period 2025-06-30 | 0001641172-25-024212 |
| 2025-08-01 | 20:15 ET | [8-K](/filings/0001641172-25-021900.md) | 3.02 Unregistered sale of equity | 0001641172-25-021900 |
| 2025-07-23 | 20:15 ET | [8-K](/filings/0001641172-25-020699.md) | 3.02 Unregistered sale of equity; 5.07 Shareholder vote results | 0001641172-25-020699 |
| 2025-07-21 | 20:30 ET | [8-K](/filings/0001641172-25-020406.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-020406 |
| 2025-07-10 | 12:55 ET | [8-K](/filings/0001641172-25-018529.md) | 5.07 Shareholder vote results | 0001641172-25-018529 |
| 2025-07-01 | 12:33 ET | [8-K](/filings/0001641172-25-017280.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-017280 |
| 2025-06-25 | 20:43 ET | [8-K](/filings/0001641172-25-016484.md) | 5.07 Shareholder vote results | 0001641172-25-016484 |
| 2025-06-06 | 20:05 ET | [8-K](/filings/0001641172-25-014019.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001641172-25-014019 |
| 2025-06-04 | 20:05 ET | [DEF 14A](/filings/0001641172-25-013611.md) | Proxy statement, period 2025-06-04 | 0001641172-25-013611 |
| 2025-05-30 | 21:30 ET | [8-K](/filings/0001641172-25-013122.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events | 0001641172-25-013122 |
| 2025-05-21 | 01:05 ET | [8-K](/filings/0001641172-25-011842.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-011842 |
| 2025-05-20 | 20:05 ET | [10-Q](/filings/0001641172-25-011710.md) | Quarterly report, period 2025-03-31 | 0001641172-25-011710 |

Page 1 of 6. [Older](/companies/ivf/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.